Indivior Pharmaceuticals (INDV) Research & Development (2024 - 2026)

Indivior Pharmaceuticals' Research & Development history runs 3 years deep, the most recent figure standing at $16.0 million for Q1 2026.

• In Q1 2026, Research & Development fell 27.27% year-over-year to $16.0 million; the TTM figure through Mar 2026 stood at $91.0 million (down 9.9% YoY), while the FY2025 annual figure was $97.0 million, down 9.35% from the prior year.
• Research & Development was $16.0 million for Q1 2026 at Indivior Pharmaceuticals, down from $21.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $33.0 million in Q3 2025 to a low of $16.0 million in Q1 2026.
• Historically, Research & Development has averaged $24.4 million across 3 years, with a median of $22.0 million in 2024.
• Biggest YoY gain for Research & Development was 50.0% in 2025; the steepest drop was 32.26% in 2025.
• A 3-year view of Research & Development shows it stood at $31.0 million in 2024, then slumped by 32.26% to $21.0 million in 2025, then declined by 23.81% to $16.0 million in 2026.
• The last three Research & Development figures came in at $16.0 million (Q1 2026), $21.0 million (Q4 2025), and $33.0 million (Q3 2025), per Business Quant data.